Login / Signup
Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol.
Jun Tao Huang
Jian-Hong Zhong
Jie Zhang
Wen Feng Gong
Liang Ma
Le Qun Li
Bang-De Xiang
Published in:
BMJ open (2023)
NCT05062837.
Keyphrases
</>
randomized controlled trial
open label
liver metastases
placebo controlled